Hansa Biopharma secures billion deal: “Profitability within reach”

Lund-based Hansa Biopharma is raising more than SEK 1bn through a new licensing agreement for its in-house developed transplant drug imlifidase.

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm

Licensavtal ska ge Roche nya vägar in i hjärnan

Läkemedelsbolaget Roche ska testa ett nytt sätt att transportera läkemedel till hjärnan – med hjälp av transportmolekyler från Bostonbaserade Manifold Bio.

Nytt samarbete: Chat GPT flyttar in i Lundbecks laboratorier

Den danska läkemedelskoncernen Lundbeck tar hjälp av Open AI för att påskynda forskning och effektivisera arbetet inom hela verksamheten.

Strategic Clarity: The New Currency in Life Science

In an industry shaped by rapid regulatory changes and global competition, leading life science companies are rethinking what it takes to succeed. Increasingly, ...

Tar in nästan halv miljard för utökad studie i lungfibros

Svenska Vicore Pharma, som utvecklar läkemedel mot allvarliga lungsjukdomar, har tagit in omkring 455 miljoner kronor i en riktad nyemission.

ZEISS Quality Innovations Worldwide

All events now in one video.

Gene therapy restored hearing in children with congenital deafness

Eleven out of twelve children with congenital deafness showed improvements in a study testing Regeneron’s gene therapy for hereditary hearing loss. The U.S. com...

Samarbete ska ta Tirmed Pharmas eksembehandling in i klinisk fas

Tirmed Pharma ingår ett fördjupat samarbete med Lundbaserade Zelmic om formulering och tillverkning av bolagets läkemedelskandidat för autoimmuna hudsjukdomar.

Heart Monitoring in Breast Cancer – Essential or Excessive?

Trastuzumab and related drugs have transformed breast cancer treatment and dramatically improved survival rates. But the close cardiac monitoring required durin...

How the Nobel discovery is used in drug development

Regulatory T cells keep the immune system in check, a discovery now awarded the 2025 Nobel Prize in Physiology or Medicine. Qiang Pan Hammarström explains how t...

New ATMP center inaugurated: “In the future, we will see cell and gene therapies in all clinics”

Karolinska Institutet and Karolinska University Hospital’s new ATMP center was inaugurated in Flemingsberg, south of Stockholm. “The ATMP Center is not just a p...

Alvotech flyttar in i svenskt life sciene-kluster

Isländska Alvotech, noterade på Stockholmsbörsen, flyttar in på Campus Solna. ”Alvotech strävar efter att avsevärt expandera sin forsknings- och utvecklingsverk...

Top 10 biggest drug launches 2026

Two presumed sales rockets – both in obesity and type 2 diabetes – top a list of potential blockbusters expected to launch in the United States in 2026.

New ZEISS Crossbeam 750 FIB-SEM for high-accuracy sample preparation workflows

Advances in simultaneous SEM imaging while FIB milling provide unmatched feedback for precision endpointing.

“We develop vaccines no one else is developing”

Vaccines delivered via patches rather than injections. Future solutions could fundamentally reshape global health. Meet the man leading efforts to distribute va...

More than 150 jobs cut as Merck scales back vaccin production

Merck & Co, known as MSD in Europe, is hitting the brakes following a sharp decline in demand for its HPV vaccine Gardasil. Production at its facility in Durham...

GU Ventures AB

Upcoming training: Introduction to ISO 15189:2022

Do you work with quality management in a medical laboratory? Don’t miss our ISO 15189:2022 online training course on May 12-13th — designed to help you understa...

Mercodia AB

Upcoming training: Cybersecurity standards for medical devices

This 1-day course on Cybersecurity standards for medical devices is designed to help professionals gain an understanding of the current standards within cyberse...

Italienskt bolag köper Catalyst i storaffär

Det italienska läkemedelsbolaget Angelini Pharma köper Catalyst Pharmaceuticals och tar därmed ett stort kliv in på den amerikanska marknaden för hjärnhälsa och...

Egetis säkrar 350 miljoner och förbereder USA-lansering

Stockholmsbaserade Egetis Therapeutics har tagit in 350 miljoner kronor i en övertecknad riktad nyemission. Aktien lyfte i onsdagens inledande handel.

World’s highest resolution X-ray microscope

ZEISS VersaXRM 730.